ESOC 2026 highlights: Blood pressure management, neuroprotection and widening inequalities shape stroke discussions in Maastricht #VoiceOfStroke [caption id="attachment_101685" align="alignright" width="300"] © European Stroke Organisation #VoiceOfStroke[/caption] At the 12th European Stroke Organisation Conference 2026, late-breaking clinical trial data and population-level analyses ...

      The European Stroke Organisation (ESO) has issued a renewed call for immediate national action following the publication of the mid-term review and update of the Stroke Action Plan for Europe 2018–2030 (SAP-E). Published in the European Stroke Journal, ...

It is my pleasure to introduce the 2025 of touchREVIEWS in Neurology, which brings together an exceptional collection of reviews, original research and congress highlights that reflect the continued evolution of neurological science and clinical innovation. This issue opens with Jelle ...

Acute ischaemic stroke management Recent randomized controlled trials (RCTs) comparing bridging intravenous thrombolysis (IVT) with tissue plasminogen activator (tPA) to direct endovascular treatment (EVT) for large-vessel occlusion (LVO) strokes within 4.5 hours of onset have failed to show inferiority of direct ...

Policymakers, clinicians, researchers, and patient advocates gathered at the European Parliament in Brussels for the event “Closing the Gaps in Stroke Care: A Call to Action for Europe.” Jointly hosted by MEP Billy Kelleher (Ireland) and MEP Romana Jerković (Croatia), alongside the European Stroke Organisation (ESO) and the Stroke Alliance for Europe (SAFE), the meeting highlighted the urgent need to align national and EU health strategies around one cohesive framework, the Stroke Action Plan for Europe (SAPE).

At Nordic Stroke 2025, experts from across the region explored advances in stroke prevention, treatment, and rehabilitation, with a strong focus on quality assessment and multidisciplinary stroke unit care. In this interview, Dr Hanne Krarup Christensen discusses emerging models of personalised stroke management and evolving standards for certification and outcome improvement.

Dr Ellis van Etten, vascular neurologist and clinical scientist at Leiden University Medical Center, specializes in cerebral amyloid angiopathy and other types of cerebral small vessel disease. With early research training at J. Philip Kistler Stroke Research Center at Massachusetts General Hospital, and a PhD on cerebral amyloid angiopathy at Leiden University, she is now actively contributing to international research, including participation in a multicentre phase II trial.

Nominated as a touchNEUROLOGY Future Leader 2025, and in collaboration with the European Stroke Organisation (ESO), Dr Björn Logi Thorarinsson, a neurologist and stroke specialist from Iceland (Landspitali University Hospital Reykjavik) has led major innovations in acute stroke care both nationally and across Europe. Currently the Chief Operating Officer of the Stroke Action Plan for Europe, Dr Thorarinsson speaks to touchNEUROLOGY about the pivotal moments that shaped his career, the transformative impact of teamwork in implementing 24/7 stroke services in Iceland, and the future of stroke care as a multi-disciplinary, protocol-driven endeavour.

As a touchNEUROLOGY Future Leader 2025, Dr Antonio Ciacciarelli shares what drew him to neurology, the lasting impact of mentorship, and why recent advances in stroke care are redefining outcomes. He reflects on the privilege of inspiring others, and the promise of neuroprotection as the next frontier in vascular neurology.